These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Willingness to Pay for a Newborn Screening Test for Spinal Muscular Atrophy. Lin PJ; Yeh WS; Neumann PJ Pediatr Neurol; 2017 Jan; 66():69-75. PubMed ID: 27769729 [TBL] [Abstract][Full Text] [Related]
8. 190 th ENMC international workshop: Spinal muscular atrophy with respiratory distress/distal spinal muscular atrophy type 1: 11-13 May 2012, Naarden, The Netherlands. van der Pol WL; Talim B; Pitt M; von Au K Neuromuscul Disord; 2013 Jul; 23(7):602-9. PubMed ID: 23726377 [No Abstract] [Full Text] [Related]
9. Reply to: The need for evidence-based treatment decisions in spinal muscular atrophy type 0. Mercuri E; Tiberi E; Costa S; Pane M; Priolo F; Romeo D; de Sanctis R; Tiziano D; Conti G; Vento G Ann Clin Transl Neurol; 2021 Oct; 8(10):2093. PubMed ID: 34546660 [No Abstract] [Full Text] [Related]
10. Prospective analysis of strength in spinal muscular atrophy. DCN/Spinal Muscular Atrophy Group. Iannaccone ST; Russman BS; Browne RH; Buncher CR; White M; Samaha FJ J Child Neurol; 2000 Feb; 15(2):97-101. PubMed ID: 10695894 [TBL] [Abstract][Full Text] [Related]
11. Delay in Diagnosis of Spinal Muscular Atrophy: A Systematic Literature Review. Lin CW; Kalb SJ; Yeh WS Pediatr Neurol; 2015 Oct; 53(4):293-300. PubMed ID: 26260993 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Finkel RS; Mercuri E; Meyer OH; Simonds AK; Schroth MK; Graham RJ; Kirschner J; Iannaccone ST; Crawford TO; Woods S; Muntoni F; Wirth B; Montes J; Main M; Mazzone ES; Vitale M; Snyder B; Quijano-Roy S; Bertini E; Davis RH; Qian Y; Sejersen T; Neuromuscul Disord; 2018 Mar; 28(3):197-207. PubMed ID: 29305137 [TBL] [Abstract][Full Text] [Related]
13. [Distal spinal-muscular atrophy 1 (DSMA1 or SMARD1)]. Kaindl AM; Guenther UP; Rudnik-Schöneborn S; Varon R; Zerres K; Gressens P; Schuelke M; Hubner C; von Au K Arch Pediatr; 2008 Oct; 15(10):1568-72. PubMed ID: 18804971 [TBL] [Abstract][Full Text] [Related]
14. Facioscapulohumeral type spinal muscular atrophy: report of a case. Hsu SC; Wang PJ; Chen CF; Shen YZ Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1989; 30(1):40-5. PubMed ID: 2637583 [TBL] [Abstract][Full Text] [Related]
15. [Infantile spinal muscular atrophy. Description of 2 cases of Werdnig-Hoffmann disease]. Priora U; Quaglia P; Vivalda M; Giachino-Amistà MT; Domeneghetti G; Sardi R Minerva Pediatr; 1987 Sep; 39(17-18):709-14. PubMed ID: 3437861 [No Abstract] [Full Text] [Related]
16. Action potentials in muscular atrophy of neurogenic origin. BUCHTHAL F; PINELLI P Neurology; 1953 Aug; 3(8):591-603. PubMed ID: 13087579 [No Abstract] [Full Text] [Related]
17. Spinal muscular atrophy with respiratory distress type 1 (SMARD1). Kaindl AM; Guenther UP; Rudnik-Schöneborn S; Varon R; Zerres K; Schuelke M; Hübner C; von Au K J Child Neurol; 2008 Feb; 23(2):199-204. PubMed ID: 18263757 [TBL] [Abstract][Full Text] [Related]